# Bristol-Myers Squibb Company (BMY) — Q3-2011 Earnings Results

**Report date:** 2011-10-27 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/BMY/earnings/Q3-2011

## Post-Earnings Brief

### Headline

Bristol Myers Squibb Beats on EPS, Stock Up 0.34%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.61 | N/A | +4.81% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management expressed confidence in the company's strategic direction. They emphasized the importance of innovation in their product pipeline.

**Key quotes:**

> Management highlighted the strong performance in key therapeutic areas.

> They noted ongoing investments in research and development to drive future growth.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Bristol Myers Squibb's earnings report indicates a positive surprise on EPS, which contributed to a slight increase in stock price. The management's focus on key therapeutic areas and R&D investments suggests a commitment to long-term growth. However, the lack of revenue data and guidance leaves some uncertainty for investors.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/BMY/earnings/Q3-2011_